GE Healthcare has launched Laboratory Asset Management Assessment (Lama), a consultative service for optimised laboratory asset management.
Lama evaluates a service programme by obtaining information about current expenditures, asset inventory and quality of service; it identifies inefficiencies, cost and resource redundancy and missing information and data.
The service compares the current programme with industry benchmarks and best practices and provides an unbiased and data-driven analysis to achieve optimal results, according to the company.
Lama is a disciplined process designed to create an actionable assessment by: analysing and understanding the current service model, including scope, access to information and processes; performing stakeholder analysis to understand the perception of key individuals who rely on the service model; performing an inventory and tagging all assets within the scope of the project; comparing the customer programme with industry benchmarks and best practices; and presenting the final output report to a client-steering committee to review recommendations and observations.
Lama has been piloted with two large biopharmaceutical companies.
The findings reports enabled each company to articulate the business case for how best to optimise its current service model.
Lama is part of GE Healthcare's Scientific Asset Services (SAS), offering support throughout the lifecycle of all assets from pre-purchase planning and financing through installation and moves to disposal.
Proprietary tools capture this data, enabling information-driven decisions for asset management to be made.
The cost for a Lama assessment will be refunded if a customer commits to an asset management programme from GE Healthcare within six months of the assessment.
